🇺🇸 FDA
Pipeline program

NaCl 0.9%, TRANEXAMIC ACID, TERLIPRESSIN

APHP200043

Phase 3 small_molecule active

Quick answer

NaCl 0.9%, TRANEXAMIC ACID, TERLIPRESSIN for Hemoptysis, whatever the cause, with the exception of cystic fibrosis is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Hemoptysis, whatever the cause, with the exception of cystic fibrosis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials